New Therapies

The MMRF partners with leading cancer centers, the most talented researchers, and the pharmaceutical and biotech industries to deliver much-needed new treatments to patients.  Our collaboration has led to the FDA approval of four new treatments for multiple myeloma in just four years, an achievement unprecedented in oncology.  These treatments are now extending the lives of patients worldwide.